S. Peyrard

500 total citations
16 papers, 357 citations indexed

About

S. Peyrard is a scholar working on Genetics, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, S. Peyrard has authored 16 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in S. Peyrard's work include Hormonal Regulation and Hypertension (4 papers), Tuberous Sclerosis Complex Research (3 papers) and Mesenchymal stem cell research (2 papers). S. Peyrard is often cited by papers focused on Hormonal Regulation and Hypertension (4 papers), Tuberous Sclerosis Complex Research (3 papers) and Mesenchymal stem cell research (2 papers). S. Peyrard collaborates with scholars based in France, United States and Switzerland. S. Peyrard's co-authors include Michel Azizi, Anne Blanchard, Nicolas Chartrel, Pierre Corvol, Hubert Vaudry, Xavier Iturrioz, Catherine Llorens‐Cortés, Nadia De Mota, P Bruneval and Laetitia Pidial and has published in prestigious journals such as Journal of the American Society of Nephrology, Cardiovascular Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

S. Peyrard

16 papers receiving 344 citations

Peers

S. Peyrard
Nicola Marangon Switzerland
Norma Roda United States
Alan Kerby United Kingdom
Reika Kaneko Japan
Miao‐Sui Lin Taiwan
Nagwa Roshdy Egypt
Wan Azman Wan Sulaiman Malaysia
C. Hecquet France
Keisuke Sumi Japan
Nicola Marangon Switzerland
S. Peyrard
Citations per year, relative to S. Peyrard S. Peyrard (= 1×) peers Nicola Marangon

Countries citing papers authored by S. Peyrard

Since Specialization
Citations

This map shows the geographic impact of S. Peyrard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Peyrard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Peyrard more than expected).

Fields of papers citing papers by S. Peyrard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Peyrard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Peyrard. The network helps show where S. Peyrard may publish in the future.

Co-authorship network of co-authors of S. Peyrard

This figure shows the co-authorship network connecting the top 25 collaborators of S. Peyrard. A scholar is included among the top collaborators of S. Peyrard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Peyrard. S. Peyrard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Bissler, John J., Elżbieta Radzikowska, Bernard A. Zonnenberg, et al.. (2016). 757 Everolimus for renal angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: Final long-term results from EXIST-2. European Urology Supplements. 15(3). e757–e757a. 5 indexed citations
3.
Bissler, John J., J.C. Kingswood, Elżbieta Radzikowska, et al.. (2015). 1 Everolimus for renal angiomyolipoma associated with tuberous sclerosis complex (TSC) from EXIST-2: Continued efficacy and diminishing adverse events after ∼3.5 years of treatment. European Urology Supplements. 14(2). e1–e1. 4 indexed citations
4.
Beaussier, Hélène, François Coudoré, Guillaume Bobrie, et al.. (2013). CPC-065 How to Assess Medication Adherence Among Patients with Resistant Hypertension Treated with Two Different Pharmacological Intensification Strategies. European Journal of Hospital Pharmacy. 20(Suppl 1). A188.3–A189. 1 indexed citations
5.
Hamdi, Haïfa, Valérie Planat‐Benard, Alain Bel, et al.. (2011). Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections. Cardiovascular Research. 91(3). 483–491. 103 indexed citations
6.
Pham, I., Grégoire Wuerzner, Jean‐Paul Richalet, S. Peyrard, & Michel Azizi. (2010). Endothelin receptors blockade blunts hypoxia‐induced increase in PAP in humans. European Journal of Clinical Investigation. 40(3). 195–202. 24 indexed citations
7.
Frank, Michael, et al.. (2010). CLINICAL PROFILE OF PATIENTS REFERRED TO A TERTIARY HYPERTENSION UNIT IN A CITY AREA: PP.15.52. Journal of Hypertension. 28. e264–e264. 2 indexed citations
8.
Frank, Michael, Guillaume Bobrie, Michel Azizi, et al.. (2010). SUPERIORITY OF LOW DOSE DIURETICS COMBINATION OVER RENIN-ANGIOTENSIN BLOCKERS COMBINATION IN RESISTANT HYPERTENSION: PP.16.89. Journal of Hypertension. 28. e276–e276. 1 indexed citations
9.
Azizi, Michel, et al.. (2010). BLOOD PRESSURE AND POTASSIUM EFFECTS OF THE NEW DIRECT ALDOSTERONE SYNTHASE INHIBITOR, LCI699, IN PATIENTS WITH PRIMARY ALDOSTERONISM: 9D.03. Journal of Hypertension. 28. e441–e442. 2 indexed citations
10.
Kac, G., et al.. (2009). Bactericidal efficacy of a 1.5min surgical hand-rubbing protocol under in-use conditions. Journal of Hospital Infection. 72(2). 135–139. 10 indexed citations
11.
Azizi, Michel, Xavier Iturrioz, Anne Blanchard, et al.. (2008). Reciprocal Regulation of Plasma Apelin and Vasopressin by Osmotic Stimuli. Journal of the American Society of Nephrology. 19(5). 1015–1024. 116 indexed citations
12.
Blanchard, Anne, Michel Azizi, S. Peyrard, et al.. (2007). Partial Human Genetic Deficiency in Tissue Kallikrein Activity and Renal Calcium Handling. Clinical Journal of the American Society of Nephrology. 2(2). 320–325. 18 indexed citations
13.
Azarnoush, Kasra, et al.. (2007). Can erythropoietin improve skeletal myoblast engraftment in infarcted myocardium?. Interactive Cardiovascular and Thoracic Surgery. 6(3). 293–297. 5 indexed citations
14.
Agueznay, Nour El Houda, Cécile Badoual, Stéphane Hans, et al.. (2007). Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships. Clinical & Experimental Immunology. 150(1). 114–123. 21 indexed citations
15.
Kac, G., Éric Abergel, Nicolas Denarié, et al.. (2006). Evaluation of a new disinfection procedure for ultrasound probes using ultraviolet light. Journal of Hospital Infection. 65(2). 163–168. 28 indexed citations
16.
Bissery, Alvine, et al.. (2006). Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans. Clinical Pharmacology & Therapeutics. 79(1). 49–61. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicola Marangon Breakdown of academic impact, for papers by Norma Roda Breakdown of academic impact, for papers by Alan Kerby Breakdown of academic impact, for papers by Reika Kaneko Breakdown of academic impact, for papers by Miao‐Sui Lin Breakdown of academic impact, for papers by Nagwa Roshdy Breakdown of academic impact, for papers by Wan Azman Wan Sulaiman Breakdown of academic impact, for papers by C. Hecquet Breakdown of academic impact, for papers by Keisuke Sumi
Rankless by CCL
2026